BBHvsFTXHETF Comparison
VS
VanEck Biotech ETF (BBH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.6% for FTXH. BBH is up 32.7% year-to-date (YTD) with +$22M in YTD flows. FTXH performs worse with 31.52% YTD performance, and +$1.04B in YTD flows. Run a side-by-side ETF comparison of BBH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH vs FTXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 11/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH FTXH | +4.37%+5.77% | +19.27%+9.65% | +32.70%+31.52% | +38.73%+44.07% | +68.11%+80.66% | +34.27%+69.64% |
| Flows | BBH FTXH | +$15M+$63M | +$29M+$129M | +$22M+$1.04B | +$24M+$1.04B | -$123M+$1.04B | -$126M+$1.04B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH FTXH | +29.42%+20.68% | +22.89%+18.14% | +20.65%+17.29% | +21.87%+16.55% |
| Max drawdown | BBH FTXH | -6.32%-5.45% | -10.54%-7.50% | -22.78%-19.32% | -33.06%-19.32% |
| Max drawdown duration | BBH FTXH | 36d57d | 150d99d | 440d393d | 1456d393d |
Trading data
BBH | FTXH | |
Last sale 11/5/2026 at 2:30 PM | $251.01 | $43.13 |
| Previous close 11/04/2026 | $261.63 | $44.86 |
| Consolidated volume 11/04/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of October 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBH | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 11/5/2026 at 2:30 PM
Live
Closed
BBH | FTXH | |
|---|---|---|
| Last price | $251.01 | $43.13 |
| 1D performance | -4.06% | -3.86% |
| AuM | $518.81 M | $1.17 B |
| E/R | 0.35% | 0.6% |
Characteristics
BBH | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VanEck | First Trust |
| Benchmark | MVIS US Listed Biotech 25 Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 25 | 50 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | September 20, 2016 |
| ESG | No | No |
Exposure
Countries
BBH
USA
88.89%
Other
11.11%
FTXH
USA
96.23%
Other
3.77%
Sectors
BBH
Healthcare
100%
Other
-0%
FTXH
Healthcare
99.88%
Other
0.12%
Advertisement
Diversification
BBH
Total weight of top 15 holdings out of 15
85.93%
FTXH
Total weight of top 15 holdings out of 15
70.94%
Top 15 holdings
Data as of September 30, 2026
BBH
Amgen, Inc.
15.74%
Gilead Sciences, Inc.
13.28%
Vertex Pharmaceuticals, Inc.
8.21%
Regeneron Pharmaceuticals, Inc.
6.38%
Moderna, Inc.
6.35%
Natera, Inc.
5.31%
argenx SE
4.62%
IQVIA Holdings, Inc.
4.43%
Revolution Medicines, Inc.
4.17%
Illumina, Inc.
3.99%
Guardant Health, Inc.
2.97%
Alnylam Pharmaceuticals, Inc.
2.76%
BeOne Medicines Ltd.
2.74%
Biogen, Inc.
2.73%
Incyte Corp.
2.24%
FTXH
AbbVie, Inc.
7.37%
Eli Lilly & Co.
7.22%
Pfizer Inc.
7.18%
Merck & Co., Inc.
7.07%
Johnson & Johnson
7.07%
Viatris, Inc.
3.84%
Biogen, Inc.
3.74%
Gilead Sciences, Inc.
3.66%
United Therapeutics Corp.
3.61%
Amgen, Inc.
3.44%
Incyte Corp.
3.42%
Vertex Pharmaceuticals, Inc.
3.38%
Regeneron Pharmaceuticals, Inc.
3.34%
Bristol Myers Squibb Co.
3.34%
Zoetis, Inc.
3.26%
Frequently asked questions about BBH and FTXH
How have the BBH and FTXH ETFs performed in 2026?
As of November 5, 2026, BBH is up 32.7% year-to-date (YTD), while FTXH has returned 31.52%. That puts BBH better performer ahead so far this year.
Which ETF is attracting more investor money: BBH or FTXH?
Year-to-date, the BBH ETF saw +$22M in flows, compared to +$1.04B for FTXH.
Which ETF is more volatile: BBH or FTXH?
Over the past year, BBH had a volatility of 22.89%, while FTXH experienced 18.14%.
Which ETF is bigger: BBH or FTXH?
As of November 5, 2026, BBH holds $518.81 M in assets under management (AUM), while FTXH manages $1.17 B.
What sectors do the BBH and FTXH ETFs invest in?
BBH leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.
What are the top holdings of the BBH ETF and FTXH ETF?
BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. FTXH holds in its top three: AbbVie, Inc., Eli Lilly & Co. and Pfizer Inc..
Which ETF is more diversified: BBH or FTXH?
BBH holds 25 securities with 85.93% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 70.94%.
Advertisement
Advertisement
